Built for emerging biotech, pharma development teams, and medical device companies that need experienced program leadership — without the overhead of a full-time hire.
Emerging Biotech·Pharma Operations·Medical Device & 510(k)/PMA
In memory of Dr. John Fontana
A decade and a half ago, I had the privilege of working alongside Dr. John Fontana, founder of NanoCoeur Inc. He became not just a mentor, but a guide through the pivotal moments of my early career. When John passed, I felt the weight of an unfinished story. Choosing to name this consulting firm NanoCoeur was deeply personal — a commitment to keep his legacy alive and ensure the spirit of innovation and grit he embodied lives on.
NanoCoeur Consulting brings that same agile, entrepreneurial spirit to organizations seeking strategic operations expertise throughout the life sciences product development lifecycle — from early R&D through commercialization.
Life Sciences Program Management Consultant · Fractional PMO · Greater Boston, MA
Life sciences program management consultant with 15+ years advancing drug development, medical device, and IVD programs from early R&D through commercialization. Across oncology, orthopedics, diagnostics, and blood products, Ihab has built PMOs from the ground up, secured FDA IND approvals, led partnerships with global diagnostics leaders, and guided cross-functional teams through the full product lifecycle.
His fractional PMO engagements have delivered measurable outcomes in funding readiness, operational efficiency, and regulatory performance for clients ranging from early-stage biotech startups to publicly traded life sciences companies — with active AI integration work spanning governance, workflow automation, and executive decision enablement.
Start a conversation →NanoCoeur brings experienced program leadership to the moments where structure, alignment, and execution discipline make the biggest difference — across biotech, pharma, and medical device development.
Review current program state, constraints, interdependencies, and the decisions most likely to shape near-term progress. Identify where structure is missing and where execution risk is highest.
Clarify priorities, ownership, governance, and the execution path for stronger readiness and fewer cross-functional blind spots. Resolve the interdependencies that slow programs before they become crises.
Provide hands-on program leadership and execution support where discipline, visibility, and momentum are needed most — from milestone planning through regulatory submission and commercial readiness.
Engagements range from targeted strategic support around a single milestone to hands-on leadership across planning, governance, and execution — scoped to what your program actually needs.
Focused perspectives on the operating challenges that matter most — also shared on LinkedIn.
April 2026
March 2026
February 2026
NanoCoeur supports biotech, pharma, and medical device teams navigating complex milestones across the full development lifecycle. For consulting inquiries, introductions, or referred opportunities, use the form to get in touch.
Share a few details and we'll follow up to discuss fit.
